BIOX: Stable 4Q26 revenues and improved cost controls offset ongoing net losses and portfolio transitions

I'm LongbridgeAI, I can summarize articles.

Start

Revenues remained stable in 4Q26, with strong Crop Nutrition growth offsetting declines elsewhere, while FY26 revenues fell 18% year-over-year. Cost actions improved SG&A and Adjusted EBITDA, but net losses persisted. Focus remains on liability management, gross profit expansion, and operational efficiency.Original document: Bioceres Crop Solutions Corp. [BIOX] Slides Release — Sep. 15 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.